Yescarta, from Gilead’s recently acquired company Kite, was approved to treat relapsed or refractory large B-cell lymphoma following two or more lines of systemic therapy.
Specialty Pharmacy News
The newly re-launched product is Health Canada compliant and has been available for purchase online since Sept. 29.
Verzenio works by blocking certain molecules that are involved in cancer cell growth, and it joins two previously approved drugs in this class — palbociclib (Pfizer’s Ibrance) and ribociclib (Novartis’ Kisqali).
The new indication’s approval marks the 10th new indication for Keytruda in three years, Merck said.
Temptime VP global customer development Christopher Caulfield spoke with Drug Store News about how the company’s tools helps pharmacies deliver value to patients and the healthcare system.
The Distinguished Service Award is given annually to an individual who has made a sustained contribution to leadership within NASP and the specialty pharmacy industry.
Mvasi, a biosimilar of Avastin, is indicated to treat five types of cancer.